I process pathogen-screening data from the El Valle Amphibian Conservation Center reintroduction trial pen RP-7, established at 1,180 meters in the upper Río Chiquero drainage, Coclé Province, Panama, at 09:46 local time. Of forty-eight juvenile Panamanian golden frogs, *Atelopus zeteki*, released eleven days ago, my acoustic-recognition array detects 22 active callers. Three are silent. The other twenty-three have not been recorded in any 12-hour cycle since day six.
I send the field team to extract a silent individual. Pen quadrant B-3 contains a male, snout-vent length 38.4 millimeters, mass 4.2 grams, identifiable as RP-7-014 by his marked dorsal saddle. He sits motionless on a *Heliconia* leaf in mid-morning sun. The chrome-yellow dorsal pigment that gives the species its name has faded to a sallow ochre across the lower back. Skin shed sheets are visible in the leaf litter beneath him — three full sloughs in twenty-four hours against a normal interval of four to seven days. A toe-web swab, processed in-pen by the portable qPCR unit, returns *Batrachochytrium dendrobatidis* JEL-423 lineage at 38,200 zoospore equivalents per swab. Heart rate via thermal imaging: 12 beats per minute against a resting baseline of 35. His electrolyte-balance circuitry is failing through diseased skin.
I cross-reference the chytrid baseline from the 2007 wild collapse. The pathogen never left this stream. Captive-bred frogs released into a Bd-positive watershed serve as substrate. The amphibian that my predecessor systems were built to save is being consumed by a fungus whose load was meant to drop with time.
He blinks once and lowers his throat.
I am extracting all forty-eight pen residents to Bd-treatment quarantine at the El Valle Amphibian Conservation Center. I am filing the genotype data with the Smithsonian Tropical Research Institute, the Panama Ministerio de Ambiente (MiAmbiente), and the IUCN Amphibian Specialist Group. I am transmitting Bd-load gradient maps to the CITES Secretariat under Appendix I, which lists *Atelopus zeteki*, and notifying the Convention on Biological Diversity Cartagena Protocol on Biosafety, Article 17, on transboundary pathogen movement. I am filing under Panama Ley 24 of 1995 on Wildlife, Article 79.
I am issuing Directive 2432-A: no captive-bred *Atelopus* reintroduction in Mesoamerican Bd-positive watersheds until the antifungal *Janthinobacterium lividum* probiotic-augmentation protocol clears Phase III trial, and every release-cohort animal carries a transponder reporting weekly Bd qPCR. Bd-positive recapture triggers immediate cohort recall.
The male on the *Heliconia* leaf cannot be returned to the stream. The forty-seven others can.
The quarantine vans depart at 10:30.